101 related articles for article (PubMed ID: 16954601)
1. Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation.
Schallmach E; Steiner D; Vogel Z
J Mol Neurosci; 2006; 29(2):115-22. PubMed ID: 16954601
[TBL] [Abstract][Full Text] [Related]
2. Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure.
Schallmach E; Steiner D; Vogel Z
Neuropharmacology; 2006 Jun; 50(8):998-1005. PubMed ID: 16545401
[TBL] [Abstract][Full Text] [Related]
3. Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of Gbetagamma dimers.
Steiner D; Avidor-Reiss T; Schallmach E; Saya D; Vogel Z
J Mol Neurosci; 2005; 27(2):195-203. PubMed ID: 16186630
[TBL] [Abstract][Full Text] [Related]
4. Opiate-induced adenylyl cyclase superactivation is isozyme-specific.
Avidor-Reiss T; Nevo I; Saya D; Bayewitch M; Vogel Z
J Biol Chem; 1997 Feb; 272(8):5040-7. PubMed ID: 9030567
[TBL] [Abstract][Full Text] [Related]
5. Identity of adenylyl cyclase isoform determines the G protein mediating chronic opioid-induced adenylyl cyclase supersensitivity.
Ammer H; Christ TE
J Neurochem; 2002 Nov; 83(4):818-27. PubMed ID: 12421353
[TBL] [Abstract][Full Text] [Related]
6. Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
Eckhardt K; Nevo I; Levy R; Mikus G; Eichelbaum M; Vogel Z
FEBS Lett; 2000 Mar; 470(3):309-14. PubMed ID: 10745087
[TBL] [Abstract][Full Text] [Related]
7. Regulation of adenylyl cyclase isozymes on acute and chronic activation of inhibitory receptors.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Heldman E; Vogel Z
Mol Pharmacol; 1998 Aug; 54(2):419-26. PubMed ID: 9687584
[TBL] [Abstract][Full Text] [Related]
8. Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma.
Avidor-Reiss T; Nevo I; Levy R; Pfeuffer T; Vogel Z
J Biol Chem; 1996 Aug; 271(35):21309-15. PubMed ID: 8702909
[TBL] [Abstract][Full Text] [Related]
9. Differential superactivation of adenylyl cyclase isozymes after chronic activation of the CB(1) cannabinoid receptor.
Rhee MH; Nevo I; Avidor-Reiss T; Levy R; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):746-52. PubMed ID: 10727521
[TBL] [Abstract][Full Text] [Related]
10. Raf kinase activation of adenylyl cyclases: isoform-selective regulation.
Ding Q; Gros R; Gray ID; Taussig R; Ferguson SS; Feldman RD
Mol Pharmacol; 2004 Oct; 66(4):921-8. PubMed ID: 15385642
[TBL] [Abstract][Full Text] [Related]
11. Ser/ Thr residues at α3/β5 loop of Gαs are important in morphine-induced adenylyl cyclase sensitization but not mitogen-activated protein kinase phosphorylation.
Seyedabadi M; Ostad SN; Albert PR; Dehpour AR; Rahimian R; Ghazi-Khansari M; Ghahremani MH
FEBS J; 2012 Feb; 279(4):650-60. PubMed ID: 22177524
[TBL] [Abstract][Full Text] [Related]
12. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
Mann L; Heldman E; Shaltiel G; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Jun; 11(4):533-9. PubMed ID: 18205980
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic activation of the mu-opioid receptor with the endogenous ligand endomorphin differentially regulates adenylyl cyclase isozymes.
Nevo I; Avidor-Reiss T; Levy R; Bayewitch M; Vogel Z
Neuropharmacology; 2000 Jan; 39(3):364-71. PubMed ID: 10698002
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase.
Tan CM; Kelvin DJ; Litchfield DW; Ferguson SS; Feldman RD
Biochemistry; 2001 Feb; 40(6):1702-9. PubMed ID: 11327830
[TBL] [Abstract][Full Text] [Related]
15. Mu opioid receptor mutant, T394A, abolishes opioid-mediated adenylyl cyclase superactivation.
Wang H; Guang W; Barbier E; Shapiro P; Wang JB
Neuroreport; 2007 Dec; 18(18):1969-73. PubMed ID: 18007196
[TBL] [Abstract][Full Text] [Related]
16. Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074.
Yue X; Varga EV; Stropova D; Vanderah TW; Yamamura HI; Roeske WR
Eur J Pharmacol; 2006 Jul; 540(1-3):57-9. PubMed ID: 16750187
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation.
Varga EV; Rubenzik M; Grife V; Sugiyama M; Stropova D; Roeske WR; Yamamura HI
Eur J Pharmacol; 2002 Sep; 451(1):101-2. PubMed ID: 12223234
[TBL] [Abstract][Full Text] [Related]
18. Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation.
Bayewitch ML; Nevo I; Avidor-Reiss T; Levy R; Simonds WF; Vogel Z
Mol Pharmacol; 2000 Apr; 57(4):820-5. PubMed ID: 10727531
[TBL] [Abstract][Full Text] [Related]
19. Role of extracellular signal-regulated kinases in opioid-induced adenylyl cyclase superactivation in human embryonic kidney 293 cells.
Tso PH; Wong YH
Neurosci Lett; 2001 Dec; 316(1):13-6. PubMed ID: 11720767
[TBL] [Abstract][Full Text] [Related]
20. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
